The Scientist Magazine
A Lab-Stage mRNA Vaccine Targeting Ticks May Offer Protection Against Lyme and Other Tick-Borne Diseases
Lyme disease today is where cancer was 40 years ago...
Why are we always starting from scratch?
Scientists from adjacent disciplines like cancer, biology, and immunology should be brought under the tent.
Many, many thanks for your program research. I was one of the senders of a tick to your free testing program. As a Chronic Lyme sufferer, it is heartening to know there are research programs as yours that are on the battlefront of understanding Lyme, its co-infections and providing information to the public of this epidemic.
I was both moved and extremely impressed at LymeAid 2018 by the depth and breadth of your efforts. Your have done a great job distinguishing your focus among all of the various Lyme organizations. Huge kudos.
With the support of the Bay Area Lyme Foundation, we at UCSF are working to develop a cheap, sensitive, and accurate test for Lyme disease to prevent later complications.
The response we have gotten from our field staff who have received the trainings and tick-check signage has been tremendous. It has increased their awareness of Lyme disease and given them the tools to reduce exposure to ticks in the field.
Directed Funding for Lyme Projects
Leveraging innovative technologies from other fields of medicine to fuel new breakthroughs in Lyme and tick ecology, diagnostics, and treatments
Rigorous Screening & Accountability
Ensuring that dollars granted go to the projects with the greatest potential impact and results deliver on promises
100% Donation Impact
Thanks to the generous support of a private donor, 100% of funds raised go directly to research and prevention programs
Networking & Scale
Providing tools and resources to help connect the innovators in the field and speed solutions to market
Ensuring accurate and reliable information is available to the public through digital, print, and social media, and community programs. Learn more.